Project Details
Description
A multi-site randomized trial of subject-collected CMV dried blood spot testing with mobile technology support to optimize preemptive therapy late after allogeneic HCT
| Status | Active |
|---|---|
| Effective start/end date | 2/16/22 → 8/15/24 |
Funding
- FRED HUTCHINSON CANCER CENTER
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.